awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34844884-02624386-D679-4FDB-99EE-CD441AE8A69F
Q34844884-02624386-D679-4FDB-99EE-CD441AE8A69F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34844884-02624386-D679-4FDB-99EE-CD441AE8A69F
Bayesian models for cost-effectiveness analysis in the presence of structural zero costs.
P2860
Q34844884-02624386-D679-4FDB-99EE-CD441AE8A69F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34844884-02624386-D679-4FDB-99EE-CD441AE8A69F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f934154c60ab0693946574090917563fb1828e72
P2860
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial